title: ICAAC and Hamburg: Part 2. The dry salvages or, what to do with two protease inhibitors.
authors.forename: M
authors.initials: M
authors.lastname: Mascolini
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D001921:Brain / Q000378:metabolism / Q000821:virology; D018791:CD4 Lymphocyte Count; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D017320:HIV Protease Inhibitors / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics; D006801:Humans; D016879:Salvage Therapy; D019562:Viral Load
chemical_list: D017320:HIV Protease Inhibitors